ArticleVaccines2020

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine.

Caroline Boudousquié et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.